Health CanadaGeneral Alert
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Mar...
Published: February 9, 2021Recall ID: 62074Category: generalCountry: Canada
Reason for Recall / Hazard
COVID - Product safety
Product Description & Identification
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
Additional Source Details
| Field | Value |
|---|---|
| N I D | 62074 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/pfizer-biontech-covid-19-vaccine-updated-dosage-and-administration-and-post-market |
| Issue | COVID - Product safety |
| Title | Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2021-02-09 |
| Organization | Marketed health products |